Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The primary goal of the research study is to determine whether treating pancreatic cancer
patients with hydroxychloroquine in combination with gemcitabine before surgery is safe. The
secondary goal is to determine if this new treatment regimen can effectively treat pancreatic
cancer. This study will test the safety and efficacy of this combination in two parts, or
phases.